ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research

April 8, 2011

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

DCE Board Approves concepts For Grants to Develop HPV Animal Models, ALL Etiology Contracts

March 11, 1988

NCI, DOE Working Out Details Of Converting Portion Of Idaho Facility to Work On BNCT

July 1, 1988

Gene Delivery System Targets Tumor Blood Vessels In Dogs

March 27, 2009

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012